These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31926421)

  • 1. Research on information disclosure strategies of electricity retailers under new electricity reform in China.
    Jin L; Chen C; Wang X; Yu J; Long H
    Sci Total Environ; 2020 Mar; 710():136382. PubMed ID: 31926421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retailing Strategies for Power Retailers with a Generator Background Considering Energy Conservation Services under the Internet of Things.
    Dou X; Zhou J; Ding Y; Li J; Cao Y; Shan M; Yuan H
    Sensors (Basel); 2022 Sep; 22(17):. PubMed ID: 36081074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization strategy of power purchase and sale for electricity retailers in a two-tier market.
    Zhou B; Guo Y; Liu X; Li G; Gu P; Yang B
    Heliyon; 2024 Feb; 10(4):e26333. PubMed ID: 38420376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of retailers in the peer-to-peer electricity market: A single retailer perspective.
    Tushar W; Yuen C; Saha T; Chattopadhyay D; Nizami S; Hanif S; Alam JE; Poor HV
    iScience; 2021 Nov; 24(11):103278. PubMed ID: 34755098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategic Bidding of Retailers in Wholesale Markets: Continuous Intraday Markets and Hybrid Forecast Methods.
    Algarvio H; Lopes F
    Sensors (Basel); 2023 Feb; 23(3):. PubMed ID: 36772720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug policy in China: pharmaceutical distribution in rural areas.
    Dong H; Bogg L; Rehnberg C; Diwan V
    Soc Sci Med; 1999 Mar; 48(6):777-86. PubMed ID: 10190640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential pricing of pharmaceuticals and retail competition under the Robinson-Patman Act.
    Abood RR
    Am J Law Med; 1985; 11(3):293-317. PubMed ID: 3842232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What should the government do regarding health policy-making to develop community health care in Shanghai?
    Yu Y; Sun X; Zhuang Y; Dong X; Liu H; Jiang P; Yu Z; Zhang Y
    Int J Health Plann Manage; 2011; 26(4):379-435. PubMed ID: 22213259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Privatization of the medical market in socialist China: a historical approach.
    Liu G; Liu X; Meng Q
    Health Policy; 1994 Feb; 27(2):157-74. PubMed ID: 10133921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pricing Mechanism With Noncooperative Game and Revenue Sharing Contract in Electricity Market.
    Ma K; Wang C; Yang J; Hua C; Guan X
    IEEE Trans Cybern; 2019 Jan; 49(1):97-106. PubMed ID: 29990181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Information quality and health risks in Spanish-language retail websites for Chinese herbal medicine].
    Tejedor-García N; García-Pastor C; Benito-Martínez S; de Lucio-Cazaña FJ
    Gac Sanit; 2018; 32(1):54-60. PubMed ID: 28318753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug policy in China. Transformations, current status and future prospects.
    Liu X; Li S
    Pharmacoeconomics; 1997 Jul; 12(1):1-9. PubMed ID: 10169383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New frontier, new power: the retail environment in Australia's dark market.
    Carter SM
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii95-101. PubMed ID: 14645954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retailer's Dual Role in Digital Marketplaces: Reference Architectures for Retail Information Systems.
    Wulfert T; Schütte R
    SN Comput Sci; 2022; 3(3):206. PubMed ID: 35382221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the Disclosure System of the Evaluation and Approval Information of Medical Device Review in Japan].
    Chen M; Deng G; Liu J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Sep; 42(5):357-360. PubMed ID: 30358351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supply chain disruption management and evolutionarily stable strategies of retailers in the quantity-setting duopoly situation with homogeneous goods.
    Xiao T; Yu G
    Eur J Oper Res; 2006 Sep; 173(2):648-668. PubMed ID: 32288067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities and Challenges of Multinational Pharmaceutical Enterprises in Transforming Pharmaceutical Market in China.
    Hu L; Yu Z; Yuan Q; Hu Y; Ung COL
    Ther Innov Regul Sci; 2019 Mar; 53(2):207-214. PubMed ID: 29807464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
    Kato M; Ishikawa H; Okuhara T; Kiuchi T
    Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulating the sale of tobacco in New Zealand: A qualitative analysis of retailers' views and implications for advocacy.
    Robertson L; Marsh L; Hoek J; McGee R; Egan R
    Int J Drug Policy; 2015 Dec; 26(12):1222-30. PubMed ID: 26386891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.